DexCare vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
DexCare raised $192M including a $75M Series C in June 2024 led by ICONIQ Growth; its health system platform has surpassed 3M patient visits scheduled; health system customers became investors.
About
DexCare is a Seattle-based digital health company that spun out of Providence in 2021. It provides a patient access and demand management platform that helps health systems balance patient demand against available care capacity — across virtual, in-person, and urgent care settings. Its AI-driven matching engine connects patients to the most appropriate care option (right care, right time, right location), improving both patient access and health system revenue per available slot.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.